BioSpace News Archive

Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a clinical-stage oncology-focused cell therapy company, today announced early clinical findings from its ongoing TCR-T Library Phase 1/2 trial.

electroCore, Inc., a commercial-stage bioelectronic medicine company, announced that electroCore’s Chief Executive Officer, Dan Goldberger, will be participating at the H.C. Wainwright 24th Global Investment Conference and Ladenburg Thalmann 2022 Healthcare Conference.

Neuspera® Medical announced the hiring of seasoned medtech executive, Steffen Hovard as Chief Executive Officer.

ENDRA Life Sciences Inc. announces that management will present a company overview at the H.C. Wainwright 24th Annual Global Investment Conference being held September 12-14, 2022 in a virtual format and in-person in New York City and will be holding one-on-one meetings.

Ray Therapeutics, a biotech company whose mission is to restore vision to patients with blinding eye diseases, today announced the appointment of Peter Francis, M.D., Ph.D., as Chief Scientific & Medical Officer, and Jenny Holt as Senior Vice President, Program Portfolio Management.

Ansa Biotechnologies, a pioneer of next-generation DNA synthesis, announced the appointment of Lorna Neilson, Ph.D., as Chief Business Officer.

QuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that members of its management team are scheduled to participate in the Morgan Stanley 20th Annual Global Healthcare Conference in New York beginning on September 12, 2022.

Arsenal Biosciences, Inc. (ArsenalBio), a privately held programmable cell therapy company engineering advanced CAR T therapies for solid tumors, today announced the close of a $220 million Series B financing round.

Walking Fish Therapeutics, a leader in B cell engineering, announced it has appointed Georgia Erbez as Chief Operating Officer and moved to a new 22,000 square foot office and world-class laboratory in South San Francisco.

Applied DNA Sciences, Inc. announced that its wholly-owned clinical laboratory subsidiary, Applied DNA Clinical Labs, LLC, has launched monkeypox testing as a clinical reference laboratory testing service available to hospital systems and clinical labs located in New York State and in states that recognize New York’s CLEP/CLIA certification for testing.